Zhou C, Hu Y, Arkania E, Kilickap S, et al. A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004). Cancer Cell 2023 Dec 21:S1535-6108(23)00432-4. doi: 10.1016/j.ccell.2023.
PMID: 38181795